SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-20-000122
Filing Date
2020-10-29
Accepted
2020-10-29 16:23:54
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20200930.htm   iXBRL 10-Q 1922541
2 EX-31.1 exhibit311093020.htm EX-31.1 10691
3 EX-31.2 exhibit312093020.htm EX-31.2 10700
4 EX-32.1 exhibit321093020.htm EX-32.1 7321
  Complete submission text file 0001570562-20-000122.txt   7258743

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20200930.xsd EX-101.SCH 36541
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20200930_cal.xml EX-101.CAL 88428
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20200930_def.xml EX-101.DEF 228546
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20200930_lab.xml EX-101.LAB 575036
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20200930_pre.xml EX-101.PRE 371815
10 EXTRACTED XBRL INSTANCE DOCUMENT eols-20200930_htm.xml XML 1114143
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 201272970
SIC: 2834 Pharmaceutical Preparations